Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1996-05-20
2000-02-22
Campell, Bruce R.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
424452, 435325, 435465, 514 44, C12N 1585, C12N 1500, A61K 4800, A61K 948
Patent
active
060277211
ABSTRACT:
Methods and devices are provided for gene therapy using encapsulated packaging cell lines to deliver viral particles carrying at least one heterologous gene encoding at least one biologically active molecule.
REFERENCES:
patent: 3615024 (1971-10-01), Michaels
patent: 4353888 (1982-10-01), Sefton
patent: 4530901 (1985-07-01), Weissmann
patent: 4588585 (1986-05-01), Mark et al.
patent: 4629563 (1986-12-01), Wrasidlo
patent: 4861719 (1989-08-01), Miller
patent: 4868116 (1989-09-01), Morgan et al.
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 4935141 (1990-06-01), Buck et al.
patent: 4968733 (1990-11-01), Muller et al.
patent: 4976859 (1990-12-01), Wechs
patent: 4980286 (1990-12-01), Morgan et al.
patent: 5011472 (1991-04-01), Aebischer et al.
patent: 5026365 (1991-06-01), Rossini et al.
patent: 5158881 (1992-10-01), Aebischer et al.
patent: 5219740 (1993-06-01), Miller et al.
patent: 5288846 (1994-02-01), Quertermous et al.
patent: 5326859 (1994-07-01), Sugano et al.
patent: 5399346 (1995-03-01), Anderson et al.
patent: 5401410 (1995-03-01), Bell et al.
patent: 5449614 (1995-09-01), Danos et al.
patent: 5453368 (1995-09-01), Tresco et al.
patent: 5460959 (1995-10-01), Mulligan et al.
patent: 5487739 (1996-01-01), Aebischer et al.
patent: 5529774 (1996-06-01), Barba et al.
patent: 5529914 (1996-06-01), Hubbell et al.
patent: 5550050 (1996-08-01), Holland et al.
patent: 5573528 (1996-11-01), Aebischer et al.
Asai, A. et al., "Modulation of Tumor Immunogenicity of Rat Glioma Cells by s-Myc Expression: Eradication of Rat Gliomas in Vivo," Cell Growth & Differentiation, 5, pp. 1153-1158 (1994).
Barba, D. et al., "Development of Anti-Tumor Immunity Following Thymidine Kinase-Mediated Killing of Experimental Brain Tumors," Proc. Natl. Acad. Sci. USA, 91, pp. 4348-4352 (1994).
Barba, D. et al., "Thymidine Kinase-Mediated Killing of Rat Brain Tumors," Journal of Neurosurgery, 79, pp. 729-735 (1993).
Brunauer, S. et al., "Adsorption of Gases in Multimolecular Layers," The Journal of the American Chemical Society, 60, pp. 309-319 (1938).
Cabasso, I. et al., "Polysulfone Hollow Fibers. I. Spinning and Properties," Journal of Applied Polymer Science, 20, pp. 2377-2394 (1976).
Chambers, R. et al., "Comparison of Genetically Engineered Herpes Simplex Viruses for the Treatment of Brain Tumors in a scid Mouse Model of Human Malignant Glioma," Proc. Natl. Acad. Sci. USA, 92, pp. 1411-1415 (1995).
Chen, L. and Waxman, D.J., "Intratumoral Activation and Enhanced Chemotherapeutic Effect of Oxazaphosphorines Following Cytochrome P-450 Gene Transfer: Development of a Combined Chemotherapy/Cancer Gene Therapy Strategy," Cancer Research, 55, pp. 581-589 (1995).
Chiocca, E.A. et al., "Virus-Mediated Genetic Treatment of Rodent Gliomas," Gene Therapeutics: Methods and Applications of Direct Gene Transfer, pp. 245-262 (Jon A. Wolff, ed., 1994).
Chomczynski, P. and Sacchi, N., "Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction," Analytical Biochemistry, 162, pp. 156-159 (1987).
Culver, K.W. et al., "Gene Therapy for the Treatment of Malignant Brain Tumors with in Vivo Tumor Transduction with the Herpes Simplex Thymidine Kinase Gen/Ganciclovir System," Human Gene Therapy, 5, pp. 343-379 (1994).
Culver, K.W. et al., "In Vivo Gene Transfer with Retroviral Vector-Producer Cells for Treatment of Experimental Brain Tumors," Science, 256, pp. 1550-1552 (1992).
Davis, B.D., Microbiology: Including Immunology and Molecular Genetics, pp. 874-877 (Harper & Row, 3d ed. 1980).
Ezzeddine, Z.D. et al., "Selective Killing of Glioma Cells in Culture and in Vivo by Retrovirus Transfer of the Herpes Simplex Virus Thymidine Kinase Gene," The New Biologist, 3, 6, pp. 608-614 (1991).
Gandelman, K. et al., "Analysis of the Structure and Expression of the Human Dopamine D2.sub.A Receptor Gene," Journal of Neurochemistry, 56, 3, pp. 1024-1029 (1991).
Gruber, S.A., "The Case for Local Immunosuppression," Transplantation, 54, 1, pp. 1-11 (1992).
Hajihosseini, M. et al., "Evidence that Retroviruses Integrate into Post-Replication Host DNA," The EMBO Journal, 12, 13, pp. 4969-4974 (1993).
Izquierdo, M. et al., "Long-Term Rat Survival after Malignant Brain Tumor Regression by Retroviral Gene Therapy," Gene Therapy, 2, 1, pp. 66-69 (1995).
Kasahara, N. et al., "Tissue-Specific Targeting of Retroviral Vectors through Ligand-Receptor Interactions," Science, 266, pp. 1373-1376 (1994).
Krug, M.S. and Berger, S.L., "First-Strand cDNA Synthesis Primed with Oligo(dT)," Methods in Enzymology, 152, pp. 316-325 (1987).
Linskey, M.E. and Gilbert, M.R., "Glial Differentiation: A Review with Implications for New Directions in Neuro-Oncology," Neurosurgery, 36, 1, pp. 1-22 (1995).
Miyao, Y. et al., "Selective Expression of Foreign Genes in Glioma Cells: Use of the Mouse Myelin Basic Protein Gene Promoter to Direct Toxic Gene Expression," Journal of Neuroscience Research, 36, pp. 472-479 (1993).
Nabel, G.J. et al., "Immunotherapy of Malignancy by in Vivo Gene Transfer into Tumors," Human Gene Therapy, 3, pp. 399-410 (1992).
Nelsen, F.M. and Eggersten, F.T., "Determination of Surface Area: Adsorption Measurements by a Continuous Flow Method," Analytical Chemistry, 30, 8, pp. 1387-1390 (1958).
Oldfield, E.H. et al., "Gene Therapy for the Treatment of Brain Tumors Using Intra-Tumoral Transduction with the Thymidine Kinase Gene and Intravenous Ganciclovir," Human Gene Therapy, 4, pp. 39-69 (1993).
Ram, Z. et al., "The Effect of Thymidine Kinase Transduction and Ganciclovir Therapy on Tumor Vasculature and Growth of 9L Gliomas in Rats," Journal of Neurosurgery, 81, pp. 256-260 (1994).
Ram, Z. et al., "In Situ Retroviral-Mediated Gene Transfer for the Treatment of Brain Tumors in Rats," Cancer Research, 53, pp. 83-88 (1993).
Short, M.P. et al., "Gene Delivery to Glioma Cells in Rat Brain by Grafting of a Retrovirus Packaging Cell Line," Journal of Neuroscience Research, 27, pp. 427-439 (1990).
Smith, F. et al., "Virus Vectors for Gene Delivery to the Nervous System," Restorative Neurology and Neuroscience, 8, pp. 21-34 (1995).
Somia, N.V. et al., "Generation of Targeted Retroviral Vectors by Using Single-Chain Variable Fragment: An Approach to in Vivo Gene Delivery," Proc. Natl. Acad. Sci. USA, 92, pp. 7570-7574 (1995).
Strathmann, H. et al., "The Formation Mechanism of Asymmetric Membranes," Desalination, 16, pp. 179-203 (1975).
Strathmann, H., "Production of Microporous Media by Phase Inversion Processes," Materials Science of Synthetic Membranes, ACS Symposium Series 269, pp. 165-195 (1985).
Takamiya, Y. et al., "An Experimental Model of Retrovirus Gene Therapy for Malignant Brain Tumors," Journal of Neurosurgery, 79, pp. 104-110 (1993).
Takamiya, Y. et al., "Gene Therapy of Malignant Brain Tumors: A Rat Glioma Line Bearing the Herpes Simplex Virus Type 1-Thymidine Kinase Gene and Wild Type Retrovirus Kills Other Tumor Cells," Journal of Neuroscience Research, 33, pp. 493-503 (1992).
Tamiya, T. et al., "Transgene Inheritance and Retroviral Infection Contribute to the Efficiency of Gene Expression in Solid Tumors Inoculated with Retroviral Vector Producer Cells," Gene Therapy, 2, pp. 531-538 (1995).
Tjuvajev, J. et al., "RG-2 Glioma Growth Attenuation and Severe Brain Edema Caused by Local Production of Interleukin-2 and Interferon-.gamma.," Cancer Research, 55, pp. 1902-1910 (1995).
Weller, M. et al., "Fas/APO-1 Gene Transfer for Human Malignant Glioma," Cancer Research, 55, pp. 2936-2944 (1995).
Wu, J.K. et al., "Bystander Tumoricidal Effect in the Treatment of Experimental Brain Tumors," Neurosurgery, 35, 6, pp. 1094-1103 (1994).
Yamada, M. et al., "Retrovirus-Mediated Gene Transfer Targeted to Malignant Glioma Cells in Murine Brain," Jpn. J. Cancer Res., 83, pp. 1244-1247 (1992).
Aebischer et al. Transplantation of neural tissue im polymer capsules, Brain Res vol. 448, pp. 364-368, 1988.
Baetge et al. Delivery of a putative Parkinson's factor (GDNF) into the rat CNS using a polymer-encapsulate cell line. 33rd annual meeting of the American Society for cell biology. No. 2567, 1993.
Zurn et al. Glia
Aebischer Patrick
Hammang Joseph P.
Campell Bruce R.
Clark Deborah J. R.
Cytotherapeutics, Inc.
Elrifi Ivon R.
Prince John T.
LandOfFree
Device and method for encapsulated gene therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Device and method for encapsulated gene therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Device and method for encapsulated gene therapy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-518096